A

Amneal Pharmaceuticals Inc
F:2DT

Watchlist Manager
Amneal Pharmaceuticals Inc
F:2DT
Watchlist
Price: 10.2 EUR 2.51%
Market Cap: 3.1B EUR

Intrinsic Value

The intrinsic value of one 2DT stock under the Base Case scenario is 16.38 EUR. Compared to the current market price of 10.2 EUR, Amneal Pharmaceuticals Inc is Undervalued by 38%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

2DT Intrinsic Value
16.38 EUR
Undervaluation 38%
Intrinsic Value
Price
A
Worst Case
Base Case
Best Case

Valuation History
Amneal Pharmaceuticals Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about 2DT?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is 2DT valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Amneal Pharmaceuticals Inc.

Explain Valuation
Compare 2DT to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about 2DT?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Amneal Pharmaceuticals Inc

Current Assets 1.8B
Cash & Short-Term Investments 201.2m
Receivables 924.1m
Other Current Assets 713.1m
Non-Current Assets 1.8B
PP&E 538.1m
Intangibles 1.2B
Other Non-Current Assets 39.5m
Current Liabilities 862.1m
Accounts Payable 998.2m
Accrued Liabilities 476.3m
Other Current Liabilities -612.4m
Non-Current Liabilities 2.8B
Long-Term Debt 2.6B
Other Non-Current Liabilities 225.1m
Efficiency

Free Cash Flow Analysis
Amneal Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Amneal Pharmaceuticals Inc

Revenue
2.9B USD
Cost of Revenue
-1.9B USD
Gross Profit
1.1B USD
Operating Expenses
-717.5m USD
Operating Income
361.5m USD
Other Expenses
-355.6m USD
Net Income
5.9m USD
Fundamental Scores

2DT Profitability Score
Profitability Due Diligence

Amneal Pharmaceuticals Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
ROIC is Increasing
Healthy Gross Margin
Sustainable 3Y Average Gross Margin
49/100
Profitability
Score

Amneal Pharmaceuticals Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

2DT Solvency Score
Solvency Due Diligence

Amneal Pharmaceuticals Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
39/100
Solvency
Score

Amneal Pharmaceuticals Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

2DT Price Targets Summary
Amneal Pharmaceuticals Inc

Wall Street analysts forecast 2DT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 2DT is 11.27 EUR with a low forecast of 10.89 EUR and a high forecast of 12.19 EUR.

Lowest
Price Target
10.89 EUR
7% Upside
Average
Price Target
11.27 EUR
11% Upside
Highest
Price Target
12.19 EUR
19% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Amneal Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for 2DT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one 2DT stock?

The intrinsic value of one 2DT stock under the Base Case scenario is 16.38 EUR.

Is 2DT stock undervalued or overvalued?

Compared to the current market price of 10.2 EUR, Amneal Pharmaceuticals Inc is Undervalued by 38%.

Back to Top